ObsEva SA

📍 Plan-Les-Ouates, Switzerland🗓 Founded 2012👥 36 employees💰 Last funded Dec 2016
Biotechnology Research🌐 obseva.com
Website LinkedIn
Innovating Women’s Reproductive Health and Pregnancy Therapeutics ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on treating endometriosis, uterine fibroids, preterm labor and improving ART outcomes. ObsEva is listed on The NASDAQ Global Select Market and is trading under the ticker symbol "OBSV"​. For more information, please visit www.ObsEva.com.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2012
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in ObsEva SA?
ObsEva SA has 1 investors on record on gritt.io, 1 mid-stage.
When did ObsEva SA last raise funding?
The most recent investment in ObsEva SA recorded on gritt.io was in December 2016.
When was ObsEva SA founded?
ObsEva SA was founded in 2012.
What industry is ObsEva SA in?
ObsEva SA operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is ObsEva SA based?
ObsEva SA is headquartered in Plan-Les-Ouates, Switzerland.